Research Index
AOD-9604 Research Index
PSI surfaces 21 peer-reviewed studies on AOD-9604, prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
21 studies
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, Awan TM
Sports Med·2026·Review·PubMed →
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA
J Am Acad Orthop Surg Glob Res Rev·2026·Review·Wound Healing·PubMed →
Human sports drug testing by mass spectrometry.
Schänzer W, Thevis M
Mass Spectrom Rev·2017·Review·GH Activity·PubMed →
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Thomas A, Görgens C, Guddat S et al.
J Sep Sci·2016·Animal·PubMed →
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.
Kwon DR, Park GY
Ann Clin Lab Sci·2015·Animal·Anti-Inflammatory, Osteoarthritis·PubMed →
Detection and in vitro metabolism of AOD9604.
Cox HD, Smeal SJ, Hughes CM et al.
Drug Test Anal·2015·Animal·PubMed →
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.
Vanhee C, Moens G, Deconinck E et al.
Drug Test Anal·2014·Human·PubMed →
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.
Thevis M, Thomas A, Schänzer W
Expert Rev Proteomics·2014·Animal·PubMed →
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Thevis M, Schänzer W
J Pharm Biomed Anal·2014·Review·PubMed →
AOD-9604 does not influence the WADA hGH isoform immunoassay.
Orlovius AK, Thomas A, Schänzer W et al.
Drug Test Anal·2013·Animal·GH Activity·PubMed →
Current updates in the medical management of obesity.
Khan A, Raza S, Khan Y et al.
Recent Pat Endocr Metab Immune Drug Discov·2012·Review·Weight Loss·PubMed →
[Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
Zieba R
Postepy Hig Med Dosw (Online)·2007·Review·Weight Loss·PubMed →
Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
Jensen MD
Obesity (Silver Spring)·2006·Human·Weight Loss, Appetite Regulation, Cardiovascular Risk, Metabolic Syndrome·PubMed →
Obesity drugs in clinical development.
Halford JC
Curr Opin Investig Drugs·2006·Review·Weight Loss·PubMed →
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2005·Animal·PubMed →
AOD-9604 Metabolic.
Wilding J
Curr Opin Investig Drugs·2004·Review·Weight Loss·PubMed →
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2003·Animal·PubMed →
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2003·Animal·PubMed →
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.
Heffernan M, Summers RJ, Thorburn A et al.
Endocrinology·2001·Animal·Weight Loss, GH Activity·PubMed →
Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.
Heffernan MA, Thorburn AW, Fam B et al.
Int J Obes Relat Metab Disord·2001·Animal·GH Activity, Weight Loss·PubMed →
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.
Ng FM, Sun J, Sharma L et al.
Horm Res·2000·Animal·Glycemic Control, GH Activity, Weight Loss·PubMed →